CHRD vs DVN: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

DVN is the larger of the two ($48.95B market cap): the incumbent the market prices for continued execution (8.12x forward earnings, beta 0.48). CHRD is the smaller challenger ($7.33B), cheaper on forward earnings (6.81x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

CHRD vs DVN: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricCHRDDVNWhat it tells you
Market cap$7.33B$48.95BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E6.818.12Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E8.6510.08Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta0.350.48Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range70% of range48% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book0.901.17How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: CHRD is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how CHRD and DVN affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CHRD and DVN share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CHRD and DVN exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Chord Energy (CHRD) do?

Chord Energy drills and produces crude oil, natural gas and natural gas liquids across the Williston Basin, the Bakken and Three Forks acreage spread over North Dakota and eastern Montana. Today's company is the product of three combinations: Oasis Petroleum and Whiting Petroleum merged in 2022 to create Chord, ExxonMobil's XTO Williston package was bolted on in 2023, and Enerplus closed in May 2024. Scale is the point of all of it. Second-quarter 2026 volumes ran ~286.4 MBoepd, ~57.8% of it oil, and the operating story has shifted toward longer laterals, with 26 four-mile wells drilled to date and one reaching a measured depth of ~33,810 feet, the deepest in the basin.

Full CHRD guide

What does Devon Energy (DVN) do?

Devon Energy is a large US independent exploration and production company that finds and produces crude oil, natural gas, and natural gas liquids. Its portfolio is anchored in the Delaware Basin (part of the Permian) and includes positions in the Anadarko Basin, Eagle Ford, Williston, and other onshore US plays. As a producer that sells raw commodities into global markets, Devon is largely a price-taker: its revenue, margins, and shareholder payouts are driven mainly by oil and gas prices and by how efficiently it can drill and complete wells, rather than by any single product or brand.

Full DVN guide

CHRD vs DVN: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • CHRD drivers: A return framework tied to leverage, not to a promise; Longer laterals as the main cost lever.
  • DVN drivers: Oil and gas prices drive the story; Coterra merger and Permian scale.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Crude price is the dominant variable and Chord has almost nothing else to lean on: with ~58% oil in the mix and a single producing basin, a sustained slide in WTI compresses revenue, free cash flow and the variable portion of the return framework at the same time. For DVN, the dominant risk is commodity price cyclicality: with revenue tied to oil and gas prices, a global slowdown, an OPEC+ supply shift, or weak natural gas prices can compress cash flow and shrink the variable dividend and buybacks quickly.

CHRD or DVN: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CHRD if you believe its drivers more; DVN if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CHRD and DVN guides.

CHRD vs DVN: the full fundamentals

CHRD. Around ~10 times trailing and ~9.5 times forward earnings, Chord still prices like a cyclical producer rather than a growth company, even after a ~60% rise in 2026. Cash generation supports the arithmetic: ~$0.96 billion of trailing free cash flow against an ~$8.3 billion market value, with ~$1.5 billion of debt offset by ~$612 million of cash, and ~$550 million of Marcellus sale proceeds due in the fourth quarter. Third-quarter results around November 3 carry a consensus of ~$5.15 per share, and analysts expect 2027 EPS to fall back to ~$18 from ~$21.80 in 2026, which is the oil price risk showing up in the estimates.

DVN. Figures are approximate and tied to the asOf date; verify live numbers before acting, since the Coterra merger and the pending Eagle Ford sale both reshape the company's scale. At about $50 a share Devon trades near 11 times trailing and 9 times forward earnings and about 7 times EV to EBITDA, but for a commodity producer a low P/E can mislead because it may reflect price-cycle earnings that will not repeat. Free cash flow, breakeven cost per barrel, and the sustainability of the variable return are more useful lenses; consensus for the September quarter, due November 5, 2026, is about $1.27 a share.

Headline figures (approximate, October 2026): CHRD shows revenue (ttm) ~$5.96B; Q2 2026 ~$2.17B, up ~84% y/y, net income (ttm) ~$841M; Q2 2026 ~$525M, eps (ttm / forward) ~$14.86 / ~$15.94, p/e (trailing / forward) ~10.2x / ~9.5x; DVN shows revenue (ttm) ~$18.8 billion; Q2 2026 ~$7.4 billion, first full quarter with Coterra, net income (ttm) ~$3.3 billion; Q2 2026 EPS $1.57 vs $1.41 estimate, p/e (trailing / forward) ~11x / ~9x, dividend yield ~2.6% ($1.28 a year fixed).

The bottom line: CHRD vs DVN

CHRD and DVN are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CHRD and DVN exposure against your real portfolio. It is not an investment adviser.

Wondering how CHRD or DVN fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Chord Energy

Ask Walnut's AI anything about CHRD and see how it fits what you own.

FAQ

What is the difference between CHRD and DVN?

+

Chord Energy drills and produces crude oil, natural gas and natural gas liquids across the Williston Basin, the Bakken and Three Forks acreage spread over North Dakota and eastern Montana. Devon Energy is a large US independent exploration and production company that finds and produces crude oil, natural gas, and natural gas liquids. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is CHRD or DVN the better stock?

+

Neither is universally better. DVN is the larger incumbent; CHRD is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, CHRD or DVN?

+

On forward P/E (as of November 2026), CHRD trades at 6.81x and DVN at 8.12x, so CHRD is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both CHRD and DVN?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of CHRD vs DVN?

+

CHRD: Crude price is the dominant variable and Chord has almost nothing else to lean on: with ~58% oil in the mix and a single producing basin, a sustained slide in WTI compresses revenue, free cash flow and the variable portion of the return framework at the same time. Full-year 2026 free cash flow guidance near ~$1.3 billion assumes a price deck that may not hold, analysts already expect earnings to fall about 17% in 2027, the Marcellus sale still has to close, and the payout above the ~$1.30 base dividend is explicitly discretionary. Operationally, Williston wells decline steeply, so the ~$1.4 billion annual capital budget is a treadmill rather than a growth investment, and North Dakota winters, gas capture rules and takeaway constraints have all curtailed basin volumes in past years. On legal matters, Walnut found no active securities-fraud class action against Chord: the widely circulated 2024 items were plaintiff-firm investigation notices tied to the Enerplus merger terms rather than filed securities cases, and the company's periodic filings describe ordinary-course litigation, royalty-owner disputes and environmental and regulatory proceedings of the kind common to large exploration and production companies. Federal and state permitting policy, methane rules and any change in Bakken pipeline capacity remain live regulatory exposures worth tracking in each 10-Q. DVN: The dominant risk is commodity price cyclicality: with revenue tied to oil and gas prices, a global slowdown, an OPEC+ supply shift, or weak natural gas prices can compress cash flow and shrink the variable dividend and buybacks quickly. The Coterra merger adds integration and execution risk, and a large deal can distract management or fail to deliver expected synergies if operations do not mesh. Shale production also declines quickly, so Devon must keep reinvesting simply to hold output flat, and rising service and labor costs can erode margins. Regulatory and policy risk around drilling permits, methane rules, and taxes is real, as is the longer-term energy-transition question of demand for hydrocarbons. Weather, well performance, and takeaway constraints add operational variability. The Eagle Ford sale is subject to closing conditions and regulatory approvals, and it removes production along with the debt-reduction and buyback capacity it provides. Several analysts trimmed or adjusted price targets in mid-October 2026, with Mizuho moving to $65 from $68.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CHRD or DVN; figures are approximate and dated (as of November 2026). Verify current data before investing.